Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients

Non-nucleoside reverse-transcriptase inhibitor plus integrase strand transfer inhibitor–based dual therapies are an attractive simplification, nucleoside reverse transcriptase inhibitor-sparing strategy for experienced human immunodeficiency virus-infected patients. Thus, we performed a 24-week real...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Int Assoc Provid AIDS Care
Main Authors: Riccardi, Niccolò, Del Puente, Filippo, Taramasso, Lucia, Di Biagio, Antonio
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2019
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6748463/
https://ncbi.nlm.nih.gov/pubmed/30798670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2325958218821657
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki